1. Home
  2. CINT vs AVXL Comparison

CINT vs AVXL Comparison

Compare CINT & AVXL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CINT
  • AVXL
  • Stock Information
  • Founded
  • CINT 1995
  • AVXL 2004
  • Country
  • CINT Brazil
  • AVXL United States
  • Employees
  • CINT N/A
  • AVXL N/A
  • Industry
  • CINT EDP Services
  • AVXL Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • CINT Technology
  • AVXL Health Care
  • Exchange
  • CINT Nasdaq
  • AVXL Nasdaq
  • Market Cap
  • CINT 833.8M
  • AVXL 779.5M
  • IPO Year
  • CINT 2021
  • AVXL N/A
  • Fundamental
  • Price
  • CINT $5.98
  • AVXL $8.58
  • Analyst Decision
  • CINT Buy
  • AVXL Strong Buy
  • Analyst Count
  • CINT 6
  • AVXL 2
  • Target Price
  • CINT $7.72
  • AVXL $44.00
  • AVG Volume (30 Days)
  • CINT 100.3K
  • AVXL 1.0M
  • Earning Date
  • CINT 03-12-2025
  • AVXL 05-08-2025
  • Dividend Yield
  • CINT N/A
  • AVXL N/A
  • EPS Growth
  • CINT 24.21
  • AVXL N/A
  • EPS
  • CINT 0.19
  • AVXL N/A
  • Revenue
  • CINT $382,840,144.00
  • AVXL N/A
  • Revenue This Year
  • CINT $17.20
  • AVXL N/A
  • Revenue Next Year
  • CINT $14.52
  • AVXL N/A
  • P/E Ratio
  • CINT $31.92
  • AVXL N/A
  • Revenue Growth
  • CINT 6.02
  • AVXL N/A
  • 52 Week Low
  • CINT $3.34
  • AVXL $3.25
  • 52 Week High
  • CINT $8.04
  • AVXL $14.44
  • Technical
  • Relative Strength Index (RSI)
  • CINT 30.91
  • AVXL 41.53
  • Support Level
  • CINT $6.07
  • AVXL $9.21
  • Resistance Level
  • CINT $6.43
  • AVXL $9.87
  • Average True Range (ATR)
  • CINT 0.22
  • AVXL 0.54
  • MACD
  • CINT -0.03
  • AVXL -0.06
  • Stochastic Oscillator
  • CINT 10.13
  • AVXL 10.50

About CINT CI&T Inc

CI&T Inc is engaged in providing strategy, design, and software engineering services to enable digital transformation for companies. The company mainly develops customizable software through the implementation of several software solutions, including Machine Learning, Artificial Intelligence (AI), Analytics, Cloud, and Mobility technologies. The majority of the revenue is generated from the North America and Europe, followed by Asia, Pacific and Japan.

About AVXL Anavex Life Sciences Corp.

Anavex Life Sciences Corp is a clinical-stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system diseases with high unmet need. It analyzes genomic data from clinical studies to identify biomarkers, which are used to select patients that will receive the therapeutic benefit for the treatment of neurodegenerative and neurodevelopmental diseases. Its necessary compound ANAVEX 2-73 is being developed to treat Alzheimer's disease, Parkinson's disease, and potentially other central nervous system diseases, including rare diseases, such as Rett syndrome, a rare severe neurological monogenic disorder. The company's operating segment is into developing novel therapies for the management of CNS diseases.

Share on Social Networks: